56 related articles for article (PubMed ID: 20498102)
1. Cancer incidence and all-cause mortality in HIV-positive patients in Northeastern Algeria before and during the era of highly active antiretroviral therapy.
Chaabna K; Newton R; Vanhems P; Laouar M; Forman D; Boudiaf Z; Soerjomataram I
J Cancer Res Ther; 2016; 12(2):576-81. PubMed ID: 27461613
[TBL] [Abstract][Full Text] [Related]
2. Cancer risk and use of protease inhibitor or nonnucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy: the D: A: D study.
Bruyand M; Ryom L; Shepherd L; Fatkenheuer G; Grulich A; Reiss P; de Wit S; D Arminio Monforte A; Furrer H; Pradier C; Lundgren J; Sabin C;
J Acquir Immune Defic Syndr; 2015 Apr; 68(5):568-77. PubMed ID: 25763785
[TBL] [Abstract][Full Text] [Related]
3. Oral manifestations of HIV in a southeast USA population.
Patton LL; McKaig RG; Strauss RP; Eron JJ
Oral Dis; 1998 Sep; 4(3):164-9. PubMed ID: 9972166
[TBL] [Abstract][Full Text] [Related]
4. Oral manifestations in 100 Zimbabwean HIV/AIDS patients referred to a specialist centre.
Jonsson N; Zimmerman M; Chidzonga MM; Jonsson K
Cent Afr J Med; 1998 Feb; 44(2):31-4. PubMed ID: 9675968
[TBL] [Abstract][Full Text] [Related]
5. Oral lesions as markers of severe immunosuppression in HIV-infected homosexual men and injection drug users.
Begg MD; Panageas KS; Mitchell-Lewis D; Bucklan RS; Phelan JA; Lamster IB
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1996 Sep; 82(3):276-83. PubMed ID: 8884825
[TBL] [Abstract][Full Text] [Related]
6. Changing patterns of HIV infection in otolaryngology.
Birchall MA; Horner PD; Stafford ND
Clin Otolaryngol Allied Sci; 1994 Dec; 19(6):473-7. PubMed ID: 7895376
[TBL] [Abstract][Full Text] [Related]
7. Survival and Prognostic Factors for AIDS and Non-AIDS Patients with Non-Hodgkin's Lymphoma in Bahia, Brazil: A Retrospective Cohort Study.
Luz E; Marques M; Luz I; Stelitano C; Netto E; Araújo I; Brites C
ISRN Hematol; 2013; 2013():904201. PubMed ID: 24288620
[TBL] [Abstract][Full Text] [Related]
8. Are patients with inflammatory eye disease treated with systemic immunosuppressive therapy at increased risk of malignancy?
Yates WB; McCluskey PJ; Wakefield D
J Ophthalmic Inflamm Infect; 2013 May; 3(1):48. PubMed ID: 23724805
[TBL] [Abstract][Full Text] [Related]
9. Cancer in HIV-infected persons from the Caribbean, Central and South America.
Fink VI; Shepherd BE; Cesar C; Krolewiecki A; Wehbe F; Cortés CP; Crabtree-Ramírez B; Padgett D; Shafaee M; Schechter M; Gotuzzo E; Bacon M; McGowan C; Cahn P; Masys D;
J Acquir Immune Defic Syndr; 2011 Apr; 56(5):467-73. PubMed ID: 21239992
[TBL] [Abstract][Full Text] [Related]
10. AIDS and non-Hodgkin's lymphoma. Experience at an oncological center in Mexico.
Cornejo-Juárez P; Volkow-Fernández P; Avilés-Salas A; Calderón-Flores E
Rev Invest Clin; 2008; 60(5):375-81. PubMed ID: 19227434
[TBL] [Abstract][Full Text] [Related]
11. HIV-related lung cancer -- a growing concern?
Powles T; Nelson M; Bower M
Int J STD AIDS; 2003 Oct; 14(10):647-51. PubMed ID: 14596765
[TBL] [Abstract][Full Text] [Related]
12. HIV-related malignancies pre- and post-highly active antiretroviral therapy: experiences in an inner city tertiary referral centre.
Kiely B; O'Flaherty J; Surah S; Kieran J; O'Donnell D; Bergin C; Mulcahy F
Int J STD AIDS; 2010 May; 21(5):332-6. PubMed ID: 20498102
[TBL] [Abstract][Full Text] [Related]
13. The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic.
Ives NJ; Gazzard BG; Easterbrook PJ
J Infect; 2001 Feb; 42(2):134-9. PubMed ID: 11531320
[TBL] [Abstract][Full Text] [Related]
14. Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection.
Powles T; Robinson D; Stebbing J; Shamash J; Nelson M; Gazzard B; Mandelia S; Møller H; Bower M
J Clin Oncol; 2009 Feb; 27(6):884-90. PubMed ID: 19114688
[TBL] [Abstract][Full Text] [Related]
15. HIV infection and cancer in the era of highly active antiretroviral therapy (Review).
Barbaro G; Barbarini G
Oncol Rep; 2007 May; 17(5):1121-6. PubMed ID: 17390054
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
